News – Page 569 – Endpoints News

Flagship's latest boast? A startup that will 'revolutionize treatment' for 'ninety percent of human illness'

4 years ago

Sanofi enlists Adagene and its 'masking' tech to develop new I/O drugs, in a deal potentially worth $2.5B

4 years ago

SEC jumps into the FibroGen fiasco with a subpoena, probing cardio data manipulation

4 years ago

Bayer rushes support to Ukraine staff, helping with cash and housing as Russians attack major cities

4 years ago

How Operation Warp Speed clashed with Pfizer in the early days of the pandemic

4 years ago

Improving cancer drug research: FDA reworks and finalizes guidance documents

4 years ago

Novavax doubles down on promise to produce 2B Nuvaxovid doses — this year

4 years ago

CureVac establishes RNA printer-specific company as light at the end of tunnel nears

4 years ago

MarketingRx roundup: Rare disease day efforts from Pfizer, Horizon and more; J&J reboots online MG campaign

4 years ago

Pfizer joins Sanofi on the C. difficile failure train after its vaccine flopped a PhIII study

4 years ago

Epizyme joins the queue of biotechs now handing out pink slips, conserving cash

4 years ago

MarketingRx Matchup: Is it Novo Nordisk’s Ozempic or Lilly and BI’s Jardiance for the win in Type 2 ads?

4 years ago

A new JAK inhibitor earns FDA nod in myelofibrosis, setting up a fight with Incyte, Bristol Myers

4 years ago

FDA rejects Gilead’s next big HIV drug over glass vial issues

4 years ago

Bristol Myers partner comes through on IL-12 effort. Now it's Rupert Vessey's turn at bat

4 years ago

AbbVie adds to its neuro pipeline with a $1B buyout deal, bolting on a new drug aimed at Alzheimer’s

4 years ago

In the wake of patient death, Sutro says its Chinese partner is rethinking their deal and withholding $40M

4 years ago

Broad Institute lands major victory in CRISPR patent fight over UC Berkeley, Nobel winners

4 years ago

A new biotech out of Dana-Farber wants to join the long non-coding RNA party, with help from Bob Langer

4 years ago

Deserted by Sanofi, Lexicon discloses last-minute hiccup in its solo fight to get sotagliflozin approved

4 years ago

'We are ready to go': FDA OKs J&J and Legend's BCMA CAR-T, setting stage for showdown with Bristol Myers

4 years ago

Expanded Intellia CRISPR data set up showdown with Pfizer, Ionis and Alnylam in not-so-rare disease

4 years ago

GlaxoSmithKline consumer business Haleon lays out game plan after July spinout

4 years ago

Sanofi, Regeneron build their case for yet another approval for immunology star Dupixent

4 years ago

First page Previous page 566 567 568569570 571 572 Next page Last page